Pathogenesis of emphysema: from the bench to the bedside.

Chronic obstructive pulmonary disease (COPD) is characterized physiologically by expiratory flow limitation and pathologically by alveolar destruction and enlargement and small and large airway inflammation and remodeling. An imbalance between protease and antiprotease activity in the lung is proposed as the major mechanism resulting in emphysema. The imbalance is mostly due to an increase in the numbers of alveolar macrophages and neutrophils. Emphysema can also develop from increased alveolar wall cell death and/or failure in alveolar wall maintenance. Chronic inflammation and increased oxidative stress contribute to increased destruction and/or impaired lung maintenance and repair. Genetic factors may play an important role in disease susceptibility because only a minority of smokers develops emphysema. Recent literature implicates surfactant instability, malnutrition, and alveolar cell apoptosis as possible etiologies. Identification of cellular and molecular mechanisms of COPD pathogenesis is an area of active, ongoing research that may help to determine therapeutic targets for emphysema.

[1]  Peter C Gøtzsche,et al.  Alpha1-antitrypsin deficiency. , 2009, The New England journal of medicine.

[2]  E. Silverman,et al.  National Emphysema Treatment Trial state of the art: genetics of emphysema. , 2008, Proceedings of the American Thoracic Society.

[3]  Toshinori Yoshida,et al.  Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. , 2007, Physiological reviews.

[4]  K. Kostikas,et al.  Clinical implications for Vascular Endothelial Growth Factor in the lung: friend or foe? , 2006, Respiratory research.

[5]  W. Arap,et al.  State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. , 2006, Proceedings of the American Thoracic Society.

[6]  I. Rahman,et al.  Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[7]  I. Rahman,et al.  Antioxidant therapeutic targets in COPD. , 2006, Current drug targets.

[8]  S. Shapiro,et al.  Animal models of pulmonary emphysema. , 2005, Current drug targets. Inflammation and allergy.

[9]  I. Adcock,et al.  Histone acetylation and deacetylation: importance in inflammatory lung diseases , 2005, European Respiratory Journal.

[10]  D. Massaro,et al.  Hunger disease and pulmonary alveoli. , 2004, American journal of respiratory and critical care medicine.

[11]  H. Rossiter,et al.  Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. , 2004, Journal of applied physiology.

[12]  H. Coxson,et al.  Early emphysema in patients with anorexia nervosa. , 2004, American journal of respiratory and critical care medicine.

[13]  H. Du,et al.  Alveolus formation: what have we learned from genetic studies? , 2004, Journal of applied physiology.

[14]  Yan Xu,et al.  Lysosomal acid lipase deficiency causes respiratory inflammation and destruction in the lung. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[15]  F. Hsieh,et al.  Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema. , 2004, American journal of respiratory and critical care medicine.

[16]  S. Shapiro,et al.  Proteolysis in the lung , 2003, European Respiratory Journal.

[17]  R. Tuder,et al.  The pathobiological mechanisms of emphysema models: what do they have in common? , 2003, Pulmonary pharmacology & therapeutics.

[18]  L. Fabbri,et al.  Cellular and structural bases of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[19]  D. Massaro,et al.  Pulmonary alveolus formation: critical period, retinoid regulation and plasticity. , 2001, Novartis Foundation symposium.

[20]  P. Hirth,et al.  Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. , 2000, The Journal of clinical investigation.

[21]  K. Ito,et al.  Histone acetylation and deacetylation. , 2000, Methods in molecular medicine.

[22]  S. Shapiro,et al.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.

[23]  H. Sahebjami Nutrition and the pulmonary parenchyma. , 1986, Clinics in chest medicine.

[24]  R. Crystal,et al.  Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema. , 1981, Science.

[25]  R. Mecham,et al.  Chemotactic activity of elastin-derived peptides. , 1980, The Journal of clinical investigation.

[26]  A. Heller,et al.  Clinical aspects of hunger disease in adults. , 1979, Current concepts in nutrition.

[27]  M. Winick,et al.  Hunger disease. Studies by the Jewish physicians in the Warsaw Ghetto. , 1979, Current concepts in nutrition.